Our retrospective analysis of the thyroid and lipid profile in COVID-19 patients proves that patients with SARS-CoV-2 infection develop hypolipidemia with reduced levels of LDL-C that negatively correlated with CRP and that TSH levels also appear to be reduced. This evidence concerns the gene CRP and COVID-19.